A detailed history of Sargent Bickham Lagudis LLC transactions in Albemarle Corp stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 388 shares of ALB stock, worth $34,916. This represents 0.01% of its overall portfolio holdings.

Number of Shares
388
Previous 511 24.07%
Holding current value
$34,916
Previous $135,000 37.78%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

SELL
$214.02 - $325.38 $26,324 - $40,021
-123 Reduced 24.07%
388 $0
Q3 2022

Oct 27, 2022

BUY
$195.82 - $307.05 $28,393 - $44,522
145 Added 39.62%
511 $135,000
Q2 2022

Jul 13, 2022

BUY
$187.76 - $270.92 $13,706 - $19,777
73 Added 24.91%
366 $77,000
Q4 2021

Jan 18, 2022

BUY
$214.16 - $283.8 $6,210 - $8,230
29 Added 10.98%
293 $68,000
Q3 2021

Nov 05, 2021

SELL
$167.91 - $244.03 $671 - $976
-4 Reduced 1.49%
264 $58,000
Q2 2021

Jul 19, 2021

BUY
$143.7 - $176.01 $4,598 - $5,632
32 Added 13.56%
268 $45,000
Q1 2021

May 24, 2021

BUY
$140.69 - $185.25 $18,289 - $24,082
130 Added 122.64%
236 $34,000
Q4 2020

May 24, 2021

BUY
$86.73 - $149.91 $13,529 - $23,385
156 Added 195.0%
236 $34,000
Q4 2020

May 24, 2021

SELL
$86.73 - $149.91 $11,274 - $19,488
-130 Reduced 55.08%
106 $16,000
Q2 2020

Sep 07, 2021

SELL
$52.7 - $86.74 $6,587 - $10,842
-125 Reduced 60.98%
80 $6,000
Q1 2020

Sep 07, 2021

BUY
$50.9 - $94.31 $6,362 - $11,788
125 Added 156.25%
205 $12,000
Q4 2019

Sep 14, 2021

SELL
$60.74 - $73.04 $6,377 - $7,669
-105 Reduced 56.76%
80 $6,000
Q3 2019

Sep 14, 2021

BUY
$59.3 - $75.53 $4,744 - $6,042
80 Added 76.19%
185 $13,000
Q3 2018

Sep 13, 2021

BUY
$90.9 - $106.6 $9,544 - $11,193
105 New
105 $10,000
Q3 2016

Sep 13, 2021

SELL
N/A
-71 Closed
0 $0
Q2 2016

Sep 07, 2021

BUY
N/A
71
71 $6,000

Others Institutions Holding ALB

About ALBEMARLE CORP


  • Ticker ALB
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 117,129,000
  • Market Cap $10.5B
  • Description
  • Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...
More about ALB
Track This Portfolio

Track Sargent Bickham Lagudis LLC Portfolio

Follow Sargent Bickham Lagudis LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.